Drug intelligence / Profile preview

xiaoer lianhua qinggan granule

Development stage
Phase 3
Lead developer
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Xiaoer Lianhua Qinggan Granule is a Traditional Chinese Medicine (TCM) hospital preparation developed by the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. It is specifically formulated for pediatric use to treat acute upper respiratory tract infections and wind-heat cold syndrome. The formulation is based on the principles of clearing heat, detoxifying, and ventilating the lungs to relieve cough. It contains a complex mixture of herbal extracts, including Forsythia and Honeysuckle, which are traditionally used to manage symptoms such as fever, sore throat, and nasal congestion. During the COVID-19 pandemic, it was officially recognized and utilized in Tianjin as a key therapeutic for managing pediatric respiratory symptoms.

Other names
小儿连花清感颗粒Xiaoer Lianhua Qinggan Keli
02

Targets

CCR5 (C-C chemokine receptor type 5)GM-CSF (Granulocyte-macrophage colony-stimulating factor)IL8 (C-X-C Motif Chemokine Ligand 8)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)

Beyond the preview

Go deeper on xiaoer lianhua qinggan granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xiaoer lianhua qinggan granule.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call